Murine Transplanted Hepatocarcinoma Treated with HSV-TK Plasmid Delivered by Microbubble Ultrasound Exposure:Experimental Study

Nie Fang,Xu Huixiong

DOI: https://doi.org/10.3969/j.issn.1002-0101.2008.05.005

2008-01-01

Abstract:Objective To evaluate the efficiency of herpes simplex virus thymidine kinase(HSV-TK)suicide gene therapy in murine transplanted hepatocarcinoma mediated by microbubble ultrasound exposure.Methods Fourty mice bearing hepatocarcinoma subcutaneously were divided randomLy into 4 groups.plasmid HSV-TK was injected into tail vein with or without SonoVue.Pulse Doppler ultrasound was applied at a 1 MHz frequency with a 50% duty cycle and 2 W/cm2 output intensity for 5 min,and the treatment was repeated the next day.In the following 10 d,ganciclovir(GCV)was given intraperitoneally on each day.The survival time of tumor-bearing mice was observed.Expression of TK mRNA was detected by RT-PCR,and transferase-mediated dUTP nick end labeling(TUNEL)staining was used to detect apoptotic cells.Results Compared with the group mediated by ultrasound alone,HSV-TK gene treatment mediated by ultrasound combined with SonoVue for restraining tumor growth and increasing survival time of tumor-bearing mice.TK mRNA expression and apoptotic index(AI)of the tumor exposed to ultrasound was increased after the addition of SonoVue(P<0.05).Conclusions Microbubble contrast agent SonoVue with ultrasound mediated HSV-TK shows marked inhibitory effect on murine transplanted hepatocarcinoma.